Lin Liao
Impact in
-
- Diabetes Treatment and Management
- Thyroid Cancer Diagnosis and Treatment
- Thyroid Disorders and Treatments
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Diabetes Treatment and Management 12
- Thyroid Cancer Diagnosis and Treatment 12
-
- Metabolism, Diabetes, and Cancer 5
- Co-authors
- Jianjun Dong (52 shared papers)Jinming Yao (27 shared papers)Junyu Zhao (20 shared papers)Xiaojun Zhou (18 shared papers)Chunmei Xu (14 shared papers)Congcong Guo (12 shared papers)Jianjun Dong (7 shared papers)Zhongwen Zhang (6 shared papers)
- Journals
- Frontiers in Endocrinology (11 papers)Diabetes Therapy (3 papers)Medicine (3 papers)Frontiers in Oncology (3 papers)Hormone and Metabolic Research (2 papers)
- Partner nations
- ChinaUnited StatesPhilippines
In The Last Decade
Lin Liao
98 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 96
- Endocrinology, Diabetes and Metabolism 309
- Nephrology 77
- Cancer Research 109
- Clinical Biochemistry 40
- Pathology and Forensic Medicine 95
Countries citing papers authored by Lin Liao
This map shows the geographic impact of Lin Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Liao more than expected).
Fields of papers citing papers by Lin Liao
This network shows the impact of papers produced by Lin Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Liao. The network helps show where Lin Liao may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Liao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 106 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 74 | |
| 2 | 2018 | 74 | |
| 3 | 2023 | 43 | |
| 4 | 2021 | 39 | |
| 5 | 2021 | 34 | |
| 6 | 2012 | 31 | |
| 7 | 2018 | 30 | |
| 8 | 2022 | 28 | |
| 9 | 2019 | 28 | |
| 10 | 2021 | 26 | |
| 11 | 2017 | 26 | |
| 12 | 2023 | 25 | |
| 13 | 2019 | 22 | |
| 14 | 2024 | 21 | |
| 15 | 2015 | 21 | |
| 16 | 2016 | 21 | |
| 17 | 2020 | 21 | |
| 18 | 2021 | 20 | |
| 19 | 2020 | 19 | |
| 20 | Activity of dihydroartemisinin against Leishmania donovani both in vitro and vivo. | 2004 | 19 |
About Lin Liao
Lin Liao is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Epidemiology, Cancer Research and Surgery, having authored 106 papers that have together received 1.2k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (12 papers), Thyroid Cancer Diagnosis and Treatment (12 papers), Pancreatic function and diabetes (6 papers), Metabolism, Diabetes, and Cancer (5 papers), Acute Kidney Injury Research (4 papers), Cancer, Lipids, and Metabolism (4 papers), Cancer-related Molecular Pathways (4 papers) and Chronic Kidney Disease and Diabetes (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (309 citations), Nephrology (77 citations), Cancer Research (109 citations), Clinical Biochemistry (40 citations) and Pathology and Forensic Medicine (95 citations). Lin Liao has collaborated with scholars based in China, United States and Philippines. Frequent co-authors include Jianjun Dong, Jinming Yao, Junyu Zhao, Xiaojun Zhou, Chunmei Xu, Congcong Guo, Jianjun Dong, Zhongwen Zhang, Dan Wei and Zhipeng Xu. Their work appears in journals such as Frontiers in Endocrinology, Diabetes Therapy, Medicine, Frontiers in Oncology and Hormone and Metabolic Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.